Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neoplasm, Residual × etoposide phosphate × 30 days × Clear all

Sponsor

Conditions

Sarcoma, Ewing 2 Rhabdoid Tumor 2 Neuroblastoma 2 Medulloblastoma 2 Ependymoma 2 Sarcoma 1 Rhabdomyosarcoma 1 Recurrence 1 Pinealoma 1 Osteosarcoma 1 Neoplasms, Germ Cell and Embryonal 1 Neoplasms 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8 1 Leukemia, Myeloid, Acute 1 Hodgkin Disease 1 Histiocytosis, Langerhans-Cell 1 Ganglioneuroblastoma 1 Carcinoma 1 Brain Neoplasms 1

Interventions

pembrolizumab 2 fludarabine 2 blinatumomab 2 tislelizumab 1 tisagenlecleucel 1 tetrathiomolybdate 1 relugolix 1 nilotinib 1 isatuximab 1 inavolisib 1 giredestrant 1 fludarabine phosphate 1 enzalutamide 1 abemaciclib 1 Transplantation 1 Monatide (IMS 3015) 1 Melphalan 1 Lenalidomide 1 Immunotherapy 1 Imatinib Mesylate 1 HMPL-013 1 Docetaxel 1 Dexamethasone 1 Dasatinib 1 Cyclophosphamide 1 Capecitabine 1 Calcium Dobesilate 1 Biological Assay 1 ALT-803 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡